Junshi Bio June 2026 Monthly Return: Share Capital Unchanged, 37.91 Million Options Outstanding

Bulletin Express07-03

Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) filed its Monthly Return for the period ended 30 June 2026, confirming that no changes occurred in authorised or issued share capital during the month.

The registered capital remained at 1.03 billion shares, split between 260.30 million H shares listed in Hong Kong and 766.39 million A shares listed on the STAR Market in Shanghai.

Issued share counts were unchanged: • H shares: 260.30 million in issue, no treasury shares. • A shares: 765.58 million in issue with 0.82 million held in treasury.

Junshi Bio affirmed compliance with the Hong Kong Stock Exchange’s 5 % public-float requirement for its H-share class.

Equity incentive programmes were stable. Outstanding options totalled 37.91 million: • H-share scheme (adopted 29 Sep 2025): 13.21 million options outstanding; full exercise could add up to 64.23 million H shares. • A-share scheme (adopted 29 Sep 2025): 24.70 million options outstanding; full exercise could utilize the existing 0.82 million treasury shares.

No options were exercised, no warrants or convertibles are outstanding, and no other share movements were recorded. The company confirmed that all regulatory and listing requirements were met for the reporting period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1166669760?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-03 16:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166669760","market":"hk","top_or_hot":-1,"title":"Junshi Bio June 2026 Monthly Return: Share Capital Unchanged, 37.91 Million Options Outstanding","media":"Bulletin Express","content":"<p>Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) filed its Monthly Return for the period ended 30 June 2026, confirming that no changes occurred in authorised or issued share capital during the month.</p>\n<p>The registered capital remained at 1.03 billion shares, split between 260.30 million H shares listed in Hong Kong and 766.39 million A shares listed on the STAR Market in Shanghai.</p>\n<p>Issued share counts were unchanged:\n• H shares: 260.30 million in issue, no treasury shares.  \n• A shares: 765.58 million in issue with 0.82 million held in treasury.</p>\n<p>Junshi Bio affirmed compliance with the Hong Kong Stock Exchange’s 5 % public-float requirement for its H-share class.</p>\n<p>Equity incentive programmes were stable. Outstanding options totalled 37.91 million:\n• H-share scheme (adopted 29 Sep 2025): 13.21 million options outstanding; full exercise could add up to 64.23 million H shares.  \n• A-share scheme (adopted 29 Sep 2025): 24.70 million options outstanding; full exercise could utilize the existing 0.82 million treasury shares.</p>\n<p>No options were exercised, no warrants or convertibles are outstanding, and no other share movements were recorded. The company confirmed that all regulatory and listing requirements were met for the reporting period.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Junshi Bio June 2026 Monthly Return: Share Capital Unchanged, 37.91 Million Options Outstanding</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJunshi Bio June 2026 Monthly Return: Share Capital Unchanged, 37.91 Million Options Outstanding\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-03 16:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) filed its Monthly Return for the period ended 30 June 2026, confirming that no changes occurred in authorised or issued share capital during the month.</p>\n<p>The registered capital remained at 1.03 billion shares, split between 260.30 million H shares listed in Hong Kong and 766.39 million A shares listed on the STAR Market in Shanghai.</p>\n<p>Issued share counts were unchanged:\n• H shares: 260.30 million in issue, no treasury shares.  \n• A shares: 765.58 million in issue with 0.82 million held in treasury.</p>\n<p>Junshi Bio affirmed compliance with the Hong Kong Stock Exchange’s 5 % public-float requirement for its H-share class.</p>\n<p>Equity incentive programmes were stable. Outstanding options totalled 37.91 million:\n• H-share scheme (adopted 29 Sep 2025): 13.21 million options outstanding; full exercise could add up to 64.23 million H shares.  \n• A-share scheme (adopted 29 Sep 2025): 24.70 million options outstanding; full exercise could utilize the existing 0.82 million treasury shares.</p>\n<p>No options were exercised, no warrants or convertibles are outstanding, and no other share movements were recorded. The company confirmed that all regulatory and listing requirements were met for the reporting period.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01877","symbol_name":"君实生物","start_time":0,"source_url":"","article_id":"1166669760","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166669760","pubTimestamp":1783068201,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) filed its Monthly Return for the period ended 30 June 2026, confirming that no changes occurred in authorised or issued share capital during the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01877":"君实生物"},"translate_title":"君实生物2026年06月月报表：股本不变3791万份期权未行使","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01877":1},"content_text":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) filed its Monthly Return for the period ended 30 June 2026, confirming that no changes occurred in authorised or issued share capital during the month.\nThe registered capital remained at 1.03 billion shares, split between 260.30 million H shares listed in Hong Kong and 766.39 million A shares listed on the STAR Market in Shanghai.\nIssued share counts were unchanged:\n• H shares: 260.30 million in issue, no treasury shares.  \n• A shares: 765.58 million in issue with 0.82 million held in treasury.\nJunshi Bio affirmed compliance with the Hong Kong Stock Exchange’s 5 % public-float requirement for its H-share class.\nEquity incentive programmes were stable. Outstanding options totalled 37.91 million:\n• H-share scheme (adopted 29 Sep 2025): 13.21 million options outstanding; full exercise could add up to 64.23 million H shares.  \n• A-share scheme (adopted 29 Sep 2025): 24.70 million options outstanding; full exercise could utilize the existing 0.82 million treasury shares.\nNo options were exercised, no warrants or convertibles are outstanding, and no other share movements were recorded. The company confirmed that all regulatory and listing requirements were met for the reporting period.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1166669760","isCrawlerRequest":true}